Unbundling Hong Kong's Niches: Value Chains in Healthcare and Mobility
Global Report·
- The article examines the structural evolution of niche markets in the Hong Kong stock market, highlighting how companies are reshaping their value chains through technological barriers or demand aggregation.
- It analyzes multiple sectors, noting that biopharma firms like RemeGen and Changfeng rely on heavy R - D investment for future exclusivity, while medical device makers face hardware commoditization.
- It concludes that companies must either become core technology innovators or terminal demand aggregators to secure pricing power and avoid being marginalized.